Sci Rep
A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma.
de Almeida Monteiro Melo Ferraz M, Nagashima JB, Venzac B, Le Gac S, Songsasen N
Ovarian cancer is the fifth cause of cancer-related mortality in women, with an expected 5-year survival rate of only 47%. High-grade serous carcinoma ...
Read More
Source: PubMed
Am. J. Surg. Pathol. 2020 Jan 27
Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.
McCluggage WG, Apellaniz-Ruiz M, Chong AL, Hanley KZ, Velázquez Vega JE, McVeigh TP, Foulkes WD
DICER1 mutations (somatic or germline) are associated with a variety of uncommon neoplasms including cervical and genitourinary embryonal rhabdomyosar ...
Read More
Source: PubMed
Eur. J. Cancer
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
Auer RC, Sivajohanathan D, Biagi J, Conner J, Kennedy E, May T
The purpose of the present review was to describe evidence-based indications for hyperthermic intraperitoneal chemotherapy (HIPEC), with cytoreductive ...
Read More
Source: PubMed
Int. J. Gynecol. Pathol. 2020 Jan 23
Misdiagnosis of High-grade Serous Ovarian Cancer With BRCA Mutation as Endometriotic Cyst Due to Its Unique Gross Morphology: A Case Report and Literature Review.
Ma Q, Yuan Y, Wang Y, Shao C, Feng W
It is believed that high-grade serous ovarian cancer (HGSOC) is a solid or multilocular-solid cancer. Here, we report the case of a 40-yr-old woman wi ...
Read More
Source: PubMed
Virchows Arch. 2020 Jan 24
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma.
Martin de la Fuente L, Westbom-Fremer S, Arildsen NS, Hartman L, Malander S, Kannisto P, Måsbäck A, Hedenfalk I
The response rate to checkpoint inhibitors for women with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum (HGSC) is modest, a ...
Read More
Source: PubMed
Sci Rep
A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma.
de Almeida Monteiro Melo Ferraz M, Nagashima JB, Venzac B, Le Gac S, Songsasen N
Ovarian cancer is the fifth cause of cancer-related mortality in women, with an expected 5-year survival rate of only 47%. High-grade serous carcinoma ...
Read More
Source: PubMed
Am. J. Surg. Pathol. 2020 Jan 27
Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.
McCluggage WG, Apellaniz-Ruiz M, Chong AL, Hanley KZ, Velázquez Vega JE, McVeigh TP, Foulkes WD
DICER1 mutations (somatic or germline) are associated with a variety of uncommon neoplasms including cervical and genitourinary embryonal rhabdomyosar ...
Read More
Source: PubMed
Eur. J. Cancer
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
Auer RC, Sivajohanathan D, Biagi J, Conner J, Kennedy E, May T
The purpose of the present review was to describe evidence-based indications for hyperthermic intraperitoneal chemotherapy (HIPEC), with cytoreductive ...
Read More
Source: PubMed
Int. J. Gynecol. Pathol. 2020 Jan 23
Misdiagnosis of High-grade Serous Ovarian Cancer With BRCA Mutation as Endometriotic Cyst Due to Its Unique Gross Morphology: A Case Report and Literature Review.
Ma Q, Yuan Y, Wang Y, Shao C, Feng W
It is believed that high-grade serous ovarian cancer (HGSOC) is a solid or multilocular-solid cancer. Here, we report the case of a 40-yr-old woman wi ...
Read More
Source: PubMed
Virchows Arch. 2020 Jan 24
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma.
Martin de la Fuente L, Westbom-Fremer S, Arildsen NS, Hartman L, Malander S, Kannisto P, Måsbäck A, Hedenfalk I
The response rate to checkpoint inhibitors for women with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum (HGSC) is modest, a ...
Read More
Source: PubMed
Sci Rep
A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma.
de Almeida Monteiro Melo Ferraz M, Nagashima JB, Venzac B, Le Gac S, Songsasen N
Ovarian cancer is the fifth cause of cancer-related mortality in women, with an expected 5-year survival rate of only 47%. High-grade serous carcinoma ...
Read More
Source: PubMed
Am. J. Surg. Pathol. 2020 Jan 27
Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.
McCluggage WG, Apellaniz-Ruiz M, Chong AL, Hanley KZ, Velázquez Vega JE, McVeigh TP, Foulkes WD
DICER1 mutations (somatic or germline) are associated with a variety of uncommon neoplasms including cervical and genitourinary embryonal rhabdomyosar ...
Read More
Source: PubMed
Eur. J. Cancer
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
Auer RC, Sivajohanathan D, Biagi J, Conner J, Kennedy E, May T
The purpose of the present review was to describe evidence-based indications for hyperthermic intraperitoneal chemotherapy (HIPEC), with cytoreductive ...
Read More
Source: PubMed
Int. J. Gynecol. Pathol. 2020 Jan 23
Misdiagnosis of High-grade Serous Ovarian Cancer With BRCA Mutation as Endometriotic Cyst Due to Its Unique Gross Morphology: A Case Report and Literature Review.
Ma Q, Yuan Y, Wang Y, Shao C, Feng W
It is believed that high-grade serous ovarian cancer (HGSOC) is a solid or multilocular-solid cancer. Here, we report the case of a 40-yr-old woman wi ...
Read More
Source: PubMed
Virchows Arch. 2020 Jan 24
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma.
Martin de la Fuente L, Westbom-Fremer S, Arildsen NS, Hartman L, Malander S, Kannisto P, Måsbäck A, Hedenfalk I
The response rate to checkpoint inhibitors for women with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum (HGSC) is modest, a ...
Read More
Source: PubMed
